Vaporox Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.5M

  • Investors
  • 9

Vaporox General Information

Description

Developer of a hyperoxia therapy technology designed to treat diabetic foot ulcers. The company's technology provides low-frequency, non-contact, and non-thermal ultrasound that atomizes a liquid with optional antimicrobials to deliver it continuously to the wound bed, enabling patients to get access to a comfortable treatment option that prevents amputations at a low cost.

Contact Information

Website
vaporox.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8375 South Willow Street
  • Suite 500
  • Lone Tree, CO 80124
  • United States
+1 (303)
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • 8375 South Willow Street
  • Suite 500
  • Lone Tree, CO 80124
  • United States
+1 (303)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vaporox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 05-Sep-2023 $2.5M Completed Generating Revenue
5. Later Stage VC (Series A) 13-Sep-2022 Completed Generating Revenue
4. Later Stage VC (Series A) 16-Aug-2021 Completed Generating Revenue
3. Seed Round 08-Mar-2021 Completed Generating Revenue
2. Seed Round 15-Jan-2020 $1.53M $2M Completed Clinical Trials - General
1. Seed Round 25-Mar-2019 $470K $470K Completed Pre-Clinical Trials
To view Vaporox’s complete valuation and funding history, request access »

Vaporox Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed Series 3
Seed Series 2 1,025,000 $0.000100 5% $1.5 $1.5 1x $1.5 12.05%
Seed Series 1 1,095,000 $0.000100 5% $0.43 $0.43 1x $0.43 12.87%
To view Vaporox’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Vaporox Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a hyperoxia therapy technology designed to treat diabetic foot ulcers. The company's technology provides lo
Therapeutic Devices
Lone Tree, CO
12 As of 2023

San Antonio, TX
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vaporox Competitors (4)

One of Vaporox’s 4 competitors is EO2 Concepts, a Venture Capital-Backed company based in San Antonio, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
EO2 Concepts Venture Capital-Backed San Antonio, TX
Natrox Venture Capital-Backed Cambridge, United Kingdom
Advanced Oxygen Therapy Formerly Private Debt Financed Oceanside, CA
Sanuwave Health Formerly PE-Backed Eden Prairie, MN
To view Vaporox’s complete competitors history, request access »

Vaporox Patents

Vaporox Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021378393-A1 Multistage vaporizer for medical treatment system Pending 16-Nov-2020
AU-2021378393-A9 Multistage vaporizer for medical treatment system Pending 16-Nov-2020
CA-3201492-A1 Multistage vaporizer for medical treatment system Pending 16-Nov-2020
EP-4243902-A1 Multistage vaporizer for medical treatment system Pending 16-Nov-2020
EP-4243902-A4 Multistage vaporizer for medical treatment system Pending 16-Nov-2020 A61M11/005
To view Vaporox’s complete patent history, request access »

Vaporox Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vaporox Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Card Sound Partners PE/Buyout Minority
Rockies Seed Fund Venture Capital Minority
Bioventus Corporation Minority
Innosphere Ventures Accelerator/Incubator Minority
Lateral Capital Management Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Vaporox FAQs

  • When was Vaporox founded?

    Vaporox was founded in 2016.

  • Where is Vaporox headquartered?

    Vaporox is headquartered in Lone Tree, CO.

  • What is the size of Vaporox?

    Vaporox has 12 total employees.

  • What industry is Vaporox in?

    Vaporox’s primary industry is Therapeutic Devices.

  • Is Vaporox a private or public company?

    Vaporox is a Private company.

  • What is Vaporox’s current revenue?

    The current revenue for Vaporox is .

  • How much funding has Vaporox raised over time?

    Vaporox has raised $12.2M.

  • Who are Vaporox’s investors?

    Card Sound Partners, Rockies Seed Fund, Bioventus, Innosphere Ventures, and Lateral Capital Management are 5 of 9 investors who have invested in Vaporox.

  • Who are Vaporox’s competitors?

    EO2 Concepts, Natrox, Advanced Oxygen Therapy, and Sanuwave Health are competitors of Vaporox.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process